Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence

Neuropsychopharmacology. 2018 Mar;43(4):928. doi: 10.1038/npp.2017.245.

Abstract

This corrects the article DOI: 10.1038/npp.2017.205.

Publication types

  • Published Erratum